These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9066865)

  • 21. A review of the pharmacoeconomics of pharmaceutical care.
    Plumridge RJ; Wojnar-Horton RE
    Pharmacoeconomics; 1998 Aug; 14(2):175-89. PubMed ID: 10186458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four core strategies used to manage outpatient specialty pharmacy costs.
    Manag Care; 2006 Dec; 15(12):53. PubMed ID: 17260846
    [No Abstract]   [Full Text] [Related]  

  • 23. Specialty pharmacy's true out-of-pocket costs.
    Manag Care; 2009 Dec; 18(12):54. PubMed ID: 20088150
    [No Abstract]   [Full Text] [Related]  

  • 24. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economics of managing atrial fibrillation: broadening the focus to include efficiency.
    Wyse DG
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):634-5. PubMed ID: 17472712
    [No Abstract]   [Full Text] [Related]  

  • 26. Are drugs within a class interchangeable?
    Furberg CD; Herrington DM; Psaty BM
    Lancet; 1999 Oct; 354(9185):1202-4. PubMed ID: 10513728
    [No Abstract]   [Full Text] [Related]  

  • 27. Disease management: linking clinical and pharmacy data.
    Drapin L
    Health Manag Technol; 1995 May; 16(6):14, 55. PubMed ID: 10142792
    [No Abstract]   [Full Text] [Related]  

  • 28. The health care cost of drug-related morbidity and mortality in nursing facilities.
    Bootman JL; Harrison DL; Cox E
    Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care.
    Hepler CD
    Pharm World Sci; 1996 Dec; 18(6):233-5. PubMed ID: 9010887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-related morbidity and mortality: an economic and clinical perspective.
    Bootman JL
    Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-Related Morbidity in Brazil: A Cost-of-Illness Model.
    de Freitas GRM; Neyeloff JL; Balbinotto Neto G; Heineck I
    Value Health Reg Issues; 2018 Dec; 17():150-157. PubMed ID: 30195236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of Pharmacy in the Promotion of Drug Safety in Pharmacotherapy].
    Satoh M
    Yakugaku Zasshi; 2018; 138(2):149-150. PubMed ID: 29386428
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy.
    Hepler CD
    Pharmacotherapy; 2004 Nov; 24(11):1491-8. PubMed ID: 15537552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System.
    Friedman GD; Collen MF; Harris LE; Van Brunt EE; Davis LS
    JAMA; 1971 Aug; 217(5):567-72. PubMed ID: 5109088
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of ambulatory care pharmacist positions under financial constraints.
    Evoy K; Fischer J; Mably M
    Am J Health Syst Pharm; 2015 Aug; 72(16):1350-3. PubMed ID: 26246290
    [No Abstract]   [Full Text] [Related]  

  • 36. Improving medication access for the uninsured.
    Weir CK; Borgmann JA
    Am J Health Syst Pharm; 2000 Nov; 57(21):2004-5. PubMed ID: 11094656
    [No Abstract]   [Full Text] [Related]  

  • 37. Medication therapy management may finally enter the mainstream.
    Sipkoff M
    Manag Care; 2007 May; 16(5):13-4. PubMed ID: 17552332
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug misuse as a disease.
    Kaatz B
    S D J Med; 1995 Dec; 48(12):421. PubMed ID: 8553052
    [No Abstract]   [Full Text] [Related]  

  • 39. CMS chief affirms incident-to billing for pharmacists is allowed.
    Traynor K
    Am J Health Syst Pharm; 2014 Jun; 71(12):977-8. PubMed ID: 24865750
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of pharmacist charges for medication therapy management services in an outpatient setting.
    Zingone MM; Malcolm KE; McCormick SW; Bledsoe KR
    Am J Health Syst Pharm; 2007 Sep; 64(17):1827-31. PubMed ID: 17724364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.